Home » News and Views » Destiny Pharma #DEST – Developing Novel Medicines that Prevent Serious Infections. Alan Green talks to CEO Neil Clark
Tags: brand communications ceo alan green, China Medical Systems, dest, destiny pharma, Neil Clark, NOVUS COMMUNICATIONS CEO ALAN GREEN, NTCD-M3, Spore COV, XF-73
You must be logged in to post a comment.
Powered by WordPress / Academica WordPress Theme by WPZOOM